Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 54 of 54 entries
View as:
Phase: N/A
Priority: Normal
Start: 05/06/21
End: 10/06/23
Due: 10/06/24
Phase: N/A
Priority: Normal
Start: 10/26/22
End: 12/10/24
Due: 12/10/25
Phase: N/A
Priority: Normal
Start: 06/21/19
End: 06/30/21
Due: 06/30/22
Phase: N/A
Priority: Normal
Start: 12/27/21
End: 12/30/24
Due: 12/30/25
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Comparative Study of BAT2506 With Simponi® in Participants With Active Psoriatic Arthritis | NCT05046431 | Bio-Thera Solutions | user2@example.com | None | 2021-05-06 | 2023-10-06 | 2024-10-06 | - | - | 2025-07-14 |
| Assessment on Efficacy and Safety of BAT2306 and Cosentyx® in Plaque Psoriasis Patients | NCT05377944 | Bio-Thera Solutions | user2@example.com | None | 2022-10-26 | 2024-12-10 | 2025-12-10 | - | - | 2025-07-14 |
| A Phase I Clinical Trial of BAT1306 and BAT8001 Injection in Patients With Solid Tumor | NCT04151329 | Bio-Thera Solutions | user2@example.com | None | 2019-06-21 | 2021-06-30 | 2022-06-30 | - | - | 2025-07-14 |
| Assessment of Safety , Clinical Efficacy with QLETLI in Non-infectious Uveitis (UV) | NCT05180526 | Bio-Thera Solutions | user2@example.com | None | 2021-12-27 | 2024-12-30 | 2025-12-30 | - | - | 2025-07-14 |